Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Matrix metalloproteinase-1 (MMP-1) fluorometric drug discovery kit, RED

 
BML-AK301-0001 96 wells 714.00 USD
Do you need bulk/larger quantities?
 
The MMP-1 Fluorometric (also known as fluorimetric) Drug Discovery Kit, RED is a complete assay system designed to screen MMP-1 inhibitors using a quenched fluorogenic substrate OMNIMMP® RED: TQ3-GABA-Pro-Cha-Abu-Smc-His-Ala-Dab(6-TAMRA)-Ala-Lys-NH2 [TQ3=quencher; GABA=4-aminobutyric acid; Cha=L-cyclohexylalanine; Abu=2-aminobutyric acid; Smc=S-methyl-L-cysteine; Dab=2,4-diaminobutyric acid; 6-TAMRA=6-tetramethylrhodamine]. TAMRA fluorescence is thoroughly quenched by the TQ3 group until cleavage by MMPs separates the two moieties.

The assays are performed in a convenient 96-well microplate format. The kit is useful to screen inhibitors of MMP-1, a potential therapeutic target. The compound NNGH is also included as a prototypic control inhibitor.

Product Details

Alternative Name:Interstitial collagenase, Fibroblast collagenase
 
Applications:Fluorescent detection, HTS
Activity assay
 
Application Notes:Designed to screen MMP-1 inhibitors using a quenched fluorogenic peptide
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Dry Ice
 
Long Term Storage:-80°C
 
Contents:1 vial MMP-1 enzyme
1 vial substrate (OMNIMMP® RED)
1 vial 6'-TAMRA calibration standard
1 vial control inhibitor (NNGH)
1 bottle (20 ml) assay buffer
1 black 96-well microplate
Instructions
 
Scientific Background:Matrix metalloproteinase-1 (MMP-1, interstitial collagenase, fibroblast collagenase) is a member of the MMP family of extracellular proteases. These enzymes play a role in many normal and disease states by virtue of their broad substrate specificities. Targets of MMP-1 include collagen, gelatin, entactin, pro-TNF-α, and the chemokine SDF-1. MMP-1 is secreted as a 52-56kDa glycosylated proenzyme (as measured by SDS-PAGE), and activated by cleavage to forms of 22-46kDa. MMP-1 is an important target for inhibitor screening due to its involvement in diseases such as cancer.
 
Technical Info/Product Notes:NCBI Reference Sequence: NM_002429

The OMNIMMP® RED substrate offers key advantages over other MMP substrates.
  1. Emission at the red end of the spectrum (576 nm after excitation at 545 nm) avoids the interference at lower wavelengths often exhibited by screening compounds, and by substances commonly found in biological samples and tissue culture medium.
  2. MMP substrate peptides display poor aqueous solubility, often with Kms near their limits of solubility, making enzyme and inhibitor kinetics difficult. MMP Kms for OMNIMMP® RED substrate are below its solubility limit.
  3. OMNIMMP® RED is avidly cleaved by MMPs, with kcat/Kms in the range of 104-106 M-1sec-1.
  4. The ultra-strong fluorescence of OMNIMMP® RED allows for substrate concentrations much lower than the Km, a condition generally desirable in inhibitor screening assays.
 
UniProt ID:P03956
 
Regulatory Status:RUO - Research Use Only
 

Product Literature References

Acetylated Resveratrol and Oxyresveratrol Suppress UVB-Induced MMP-1 Expression in Human Dermal Fibroblasts: J.E. Lee, et al.; Antioxidants 10, 1252 (2021), Abstract;

General Literature References

Matrix metalloproteinases: regulators of the tumor microenvironment: K. Kessenbrock & Z. Werb; Cell 141, 52 (2010), Abstract;
Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics : G.S. Butler & C.M. Overall; Biochemistry 48, 10830 (2009), Abstract;
Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis: I. Poola et al.; Nat. Med. 11, 481 (2005), Abstract;
Matrix Metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1: G.A. McQuibban; J. Biol. Chem. 276, 43503 (2001), Abstract;
Matrix metalloproteinases: they're not just for matrix anymore!: L.J. McCawley & L.M. Matrisian; Curr. Opin. Cell Biol. 13, 534 (2001),
Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits: L. J. MacPherson et al.; J. Med. Chem. 40, 2525 (1997), Abstract;
Mechanisms of activation of tissue procollagenase by matric metalloproteinase 3 (stromelysin): K. Suzuki, et al.; Biochemistry 29, 10261 (1990), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
SDS
Certificate of Analysis
Manual

RELATED PRODUCTS

By target:
MMP
By biological activity:
MMP Activity kit
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

All new literature pieces